-
Signature
-
/s/ Bruce Blefeld, Attorney-in-Fact
-
Stock symbol
-
ZLAB
-
Transactions as of
-
Apr 1, 2024
-
Transactions value $
-
$44,063
-
Form type
-
4
-
Date filed
-
4/3/2024, 09:45 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
$55.8K |
+3.34K |
+7.25% |
$16.72 |
49.4K |
Apr 1, 2024 |
Direct |
F1, F2 |
transaction |
ZLAB |
American Depositary Shares |
Options Exercise |
$16.9K |
+1.01K |
+2.04% |
$16.72 |
50.4K |
Apr 1, 2024 |
Direct |
F1, F2 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$22K |
-1.36K |
-2.7% |
$16.15 |
49K |
Apr 2, 2024 |
Direct |
F1, F3 |
transaction |
ZLAB |
American Depositary Shares |
Sale |
-$6.67K |
-413 |
-0.84% |
$16.15 |
48.6K |
Apr 2, 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZLAB |
Stock Options (Right to Buy) |
Award |
$0 |
+107K |
|
$0.00 |
107K |
Apr 1, 2024 |
American Depositary Shares |
107K |
$16.72 |
Direct |
F1, F4, F5 |
transaction |
ZLAB |
Restricted Share Units |
Award |
$0 |
+69.8K |
|
$0.00 |
69.8K |
Apr 1, 2024 |
American Depositary Shares |
69.8K |
|
Direct |
F1, F6, F7 |
transaction |
ZLAB |
Restricted Share Units |
Options Exercise |
$0 |
-3.34K |
-25% |
$0.00 |
10K |
Apr 1, 2024 |
American Depositary Shares |
3.34K |
|
Direct |
F1, F6, F8 |
transaction |
ZLAB |
Restricted Share Units |
Options Exercise |
$0 |
-1.01K |
-33.33% |
$0.00 |
2.02K |
Apr 1, 2024 |
American Depositary Shares |
1.01K |
|
Direct |
F1, F6, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases